GE HealthCare Technologies Inc.
GEHCHealthcareNASDAQMedical Devices · Last scanned Sep 9, 2026
Scan Results
Daily timeframeGE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States,. With a market capitalization of $30.16B, it sits in large-cap territory. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).
Market Cap
$30.16B
Beta
0.82
P/E (TTM)
15.39
P/E (Fwd)
12.34
EPS (TTM)
$4.34
EPS (Fwd)
$5.41
ROE
19.4%
ROA
5.1%
Cash
$2.08B
Total Debt
$10.54B
Free CF
$1.57B
52W Change
-9.4%
Annual Financials
Cash vs Debt
Where GEHC stands vs its 150-day and 200-day moving averages
As of the September 2, 2026 close, GEHC finished 0.89% above its 150-day moving average ($69.80) and 3.16% below its 200-day moving average ($72.72). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is GEHC overbought or oversold?
At the September 2, 2026 close, GEHC's RSI(14) was 41.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, GEHC has $2.08B in cash with $10.54B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $1.57B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 19.4%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. An ROA of 5.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $18.34B to $20.62B.
GE HealthCare Technologies Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing GEHC.